Cargando…
Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
Radiation therapy is the primary treatment in nasopharyngeal carcinoma (NPC), and the effect of radiation therapy is strongly related to the oxygen content of cancer cells. That means, it is imperative to balance the interactions between radiotherapy and anti-angiogenesis therapy when giving combina...
Autores principales: | Chen, Zhuo, Xu, Xin-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454898/ https://www.ncbi.nlm.nih.gov/pubmed/25987106 http://dx.doi.org/10.15537/smj.2015.6.11460 |
Ejemplares similares
-
Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
por: Sun, Qi, et al.
Publicado: (2022) -
Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?
por: Wenger, Justin B., et al.
Publicado: (2011) -
Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2016) -
Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
por: Raybould, Alison L, et al.
Publicado: (2020) -
Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)